Concepedia

Adverse Events Associated with Rofecoxib Therapy

B Bannwarth, Richard Tr ves, Liana Euller‐Ziegler, Denis Rolland, Philippe Ravaud, Maxime Dougados

Drug Safety · 2003 · 13 citations · 5 references

DOI

Concepts

References

5

Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis

Claire Bombardier, Loren Laine, Alise Reicin et al. · New England Journal of Medicine · 2000 · 4K citations · Full text

, , +8

Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip

Grant W. Cannon, Jacques R. Caldwell, Peter R. Holt et al. · Arthritis & Rheumatism · 2000 · 279 citations

, , +15

Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors: A report of four cases

Leslie J. Crofford, Jim C. Oates, W. Joseph McCune et al. · Arthritis & Rheumatism · 2000 · 153 citations · Full text

, , +17

Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with Rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (Ibuprofen, Diclofenac, and Nabumetone)

Alise Reicin, Deborah R. Shapiro, Rhoda Sperling et al. · The American Journal of Cardiology · 2002 · 138 citations

, , +13

Management of osteoarthritis (OA) with an unsupervised home based exercise programme and/or patient administered assessment tools. A cluster randomised controlled trial with a 2×2 factorial design

Philippe Ravaud, Bruno Giraudeau, I. Logeart et al. · Annals of the Rheumatic Diseases · 2004 · 106 citations · Full text

, , +12